<div id="subtitle">CEO: Glaxo is diversifying, fostering research for cheap new drugs for poor countries</div><div><p>Andrew Witty, who took over as GlaxoSmithKline PLC's chief executive in May 2008, has been remaking the company from a pure pharmaceutical business to a diverse healthcare conglomerate, a strategy most rivals ...

<div id="subtitle">GlaxoSmithKline offers outside scientists labs, data to fight malaria, other tropical diseases</div><div><p>Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases.</p&gt ...

<div><p>NEW YORK/LONDON (Reuters) - GlaxoSmithKline Plc hopes to seek approval by 2012 for its experimental malaria vaccine and said on Wednesday it would seek only a small profit and ensure it is widely available in hard-hit countries.</p><p>Chief Executive Andrew Witty also said the company would give away ...